» Articles » PMID: 25201111

RNA-binding Protein Misregulation in Microsatellite Expansion Disorders

Overview
Date 2014 Sep 10
PMID 25201111
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

RNA-binding proteins (RBPs) play pivotal roles in multiple cellular pathways from transcription to RNA turnover by interacting with RNA sequence and/or structural elements to form distinct RNA-protein complexes. Since these complexes are required for the normal regulation of gene expression, mutations that alter RBP functions may result in a cascade of deleterious events that lead to severe disease. Here, we focus on a group of hereditary disorders, the microsatellite expansion diseases, which alter RBP activities and result in abnormal neurological and neuromuscular phenotypes. While many of these diseases are classified as adult-onset disorders, mounting evidence indicates that disruption of normal RNA-protein interaction networks during embryogenesis modifies developmental pathways, which ultimately leads to disease manifestations later in life. Efforts to understand the molecular basis of these disorders has already uncovered novel pathogenic mechanisms, including RNA toxicity and repeat-associated non-ATG (RAN) translation, and current studies suggest that additional surprising insights into cellular regulatory pathways will emerge in the future.

Citing Articles

Alternative splicing dysregulation across tissue and therapeutic approaches in a mouse model of myotonic dystrophy type 1.

Hicks S, Frias J, Mishra S, Scotti M, Muscato D, Valero M Mol Ther Nucleic Acids. 2024; 35(4):102338.

PMID: 39391766 PMC: 11465180. DOI: 10.1016/j.omtn.2024.102338.


The polyglutamine protein ATXN2: from its molecular functions to its involvement in disease.

Costa R, Conceicao A, Matos C, Nobrega C Cell Death Dis. 2024; 15(6):415.

PMID: 38877004 PMC: 11178924. DOI: 10.1038/s41419-024-06812-5.


A new tandem repeat-enriched lncRNA XLOC_008672 promotes gastric carcinogenesis by regulating G3BP1 expression.

Li L, Yu S, Dou N, Wang X, Gao Y, Li Y Cancer Sci. 2024; 115(6):1851-1865.

PMID: 38581120 PMC: 11145122. DOI: 10.1111/cas.16172.


A comprehensive atlas of fetal splicing patterns in the brain of adult myotonic dystrophy type 1 patients.

Degener M, van Cruchten R, Otero B, Wang E, Wansink D, t Hoen P NAR Genom Bioinform. 2022; 4(1):lqac016.

PMID: 35274098 PMC: 8903011. DOI: 10.1093/nargab/lqac016.


Disrupting the Molecular Pathway in Myotonic Dystrophy.

Xing X, Kumari A, Brown J, Brook J Int J Mol Sci. 2021; 22(24).

PMID: 34948025 PMC: 8708683. DOI: 10.3390/ijms222413225.


References
1.
Davies J, Wang L, Garcia-Oroz L, Cook L, Vacher C, ODonovan D . Doxycycline attenuates and delays toxicity of the oculopharyngeal muscular dystrophy mutation in transgenic mice. Nat Med. 2005; 11(6):672-7. DOI: 10.1038/nm1242. View

2.
Batra R, Charizanis K, Swanson M . Partners in crime: bidirectional transcription in unstable microsatellite disease. Hum Mol Genet. 2010; 19(R1):R77-82. PMC: 2875054. DOI: 10.1093/hmg/ddq132. View

3.
Jansen G, Mahadevan M, Amemiya C, Wormskamp N, Segers B, Hendriks W . Characterization of the myotonic dystrophy region predicts multiple protein isoform-encoding mRNAs. Nat Genet. 1992; 1(4):261-6. DOI: 10.1038/ng0792-261. View

4.
Lemay J, Lemieux C, St-Andre O, Bachand F . Crossing the borders: poly(A)-binding proteins working on both sides of the fence. RNA Biol. 2010; 7(3):291-5. DOI: 10.4161/rna.7.3.11649. View

5.
Albrecht M, Golatta M, Wullner U, Lengauer T . Structural and functional analysis of ataxin-2 and ataxin-3. Eur J Biochem. 2004; 271(15):3155-70. DOI: 10.1111/j.1432-1033.2004.04245.x. View